Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Net Margin (2021 - 2023)

Senti Biosciences has reported Net Margin over the past 3 years, most recently at 6417.75% for Q3 2023.

  • For Q3 2023, Net Margin rose 657191.0% year-over-year to 6417.75%; the TTM value through Jun 2024 reached 488.17%, up 12430.0%, while the annual FY2025 figure was 308418.18%, N/A changed from the prior year.
  • Net Margin for Q3 2023 was 6417.75% at Senti Biosciences, up from 647.31% in the prior quarter.
  • Over five years, Net Margin peaked at 6417.75% in Q3 2023 and troughed at 1962.45% in Q2 2022.
  • A 3-year average of 400.67% and a median of 566.85% in 2023 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: crashed -80641bps in 2022 and later surged 657191bps in 2023.
  • Year by year, Net Margin stood at 486.39% in 2021, then skyrocketed by 1020bps to 4473.82% in 2022, then skyrocketed by 43bps to 6417.75% in 2023.
  • Business Quant data shows Net Margin for SNTI at 6417.75% in Q3 2023, 647.31% in Q2 2023, and 378.69% in Q1 2023.